|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM074101145 |
| 003 |
DE-627 |
| 005 |
20231222021913.0 |
| 007 |
tu |
| 008 |
231222s1980 xx ||||| 00| ||eng c |
| 028 |
5 |
2 |
|a pubmed24n0247.xml
|
| 035 |
|
|
|a (DE-627)NLM074101145
|
| 035 |
|
|
|a (NLM)7433480
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Schellen, A M
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Preliminary experience with a 'sub-50' combined oral contraceptive, containing 35 micrograms ethinyl oestradiol and 1 mg norethisterone ('NeoCon')
|
| 264 |
|
1 |
|c 1980
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 16.01.1981
|
| 500 |
|
|
|a Date Revised 21.11.2013
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a The present trend in oral contraception is clearly in favour of the 'sub-50' pills, taking into consideration the recent publications on the association between cardiovascular affections and pill intake. 'NeoCon', a combination pill containing 1 mg norethisterone and 35 micrograms ethinyl oestradiol, has been investigated in the United States, Mexico, Germany, Belgium and the United Kingdom. From all these studies, it could be concluded that it is an effective and well-tolerated oral contraceptive. From the present series, totalling 104 patients with 1232 cycles, first clinical impressions confirm the evaluations of other investigators: no pregnancies, only mild cycle disturbances disappearing after a few adaptation cycles, few side-effects and excellent tolerance. Due to the low potency and the low contents of its components, it is suggested that 'NeoCon' is appropriate for all women in general and for the younger women in particular
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
7 |
|a Contraceptives, Oral
|2 NLM
|
| 650 |
|
7 |
|a Contraceptives, Oral, Combined
|2 NLM
|
| 650 |
|
7 |
|a Ethinyl Estradiol
|2 NLM
|
| 650 |
|
7 |
|a 423D2T571U
|2 NLM
|
| 650 |
|
7 |
|a Norethindrone
|2 NLM
|
| 650 |
|
7 |
|a T18F433X4S
|2 NLM
|
| 773 |
0 |
8 |
|i Enthalten in
|t Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC)
|d 1995
|g 2(1980), 6 vom: 08., Seite 412-5
|w (DE-627)NLM023961570
|
| 773 |
1 |
8 |
|g volume:2
|g year:1980
|g number:6
|g day:08
|g pages:412-5
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_22
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_31
|
| 912 |
|
|
|a GBV_ILN_39
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a GBV_ILN_72
|
| 912 |
|
|
|a GBV_ILN_120
|
| 912 |
|
|
|a GBV_ILN_121
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 2
|j 1980
|e 6
|b 08
|h 412-5
|